Varta
← Back to stories

From BusinessLine

Center-Right Owned by The Hindu Group (Kasturi & Sons)

GSK to nearly double cancer drugs in trials next year, WSJ reports

GSK to nearly double cancer drugs in trials next year, WSJ reports

RSS excerpt

In July, GSK said it expected to have more than 20 late-stage studies by the end of 2026, with three of the seven drugs identified for faster development ‌being cancer medicines

✦ Single Source 1 news outlet reporting

Fact-Check & Bias Analysis

Reported by a single newsroom so far. Other outlets have not independently corroborated this story yet.

Coverage Bias Distribution

Based on 1 reporting publisher
Left / Center-Left 0 (0%)
Center 0 (0%)
Center-Right / Right 1 (100%)

Read more news

See all latest stories →